June 22, 2022
  • Senators Jeanne Shaheen and Susan Collins introduced legislation to reduce insulin prices and cap monthly copays at $35 or 25 percent of the list price — whichever is lower — for both commercial and Medicare plans. The bill would block pharmacy benefit managers from receiving drug discounts or rebates, which critics argue lead to higher prices. The senators said they plan to fully offset any of the bill’s projected costs. (Article here)